Paloma Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-952
Closed -$314K 1246
2024
Q2
$314K Buy
+952
New +$314K 0.01% 501
2022
Q3
Sell
-2,650
Closed -$801K 738
2022
Q2
$801K Buy
+2,650
New +$801K 0.03% 295
2021
Q3
Sell
-4,361
Closed -$1.57M 1654
2021
Q2
$1.57M Buy
4,361
+1,920
+79% +$689K 0.03% 320
2021
Q1
$688K Sell
2,441
-6,526
-73% -$1.84M 0.01% 748
2020
Q4
$2.54M Buy
8,967
+409
+5% +$116K 0.07% 200
2020
Q3
$2.35M Sell
8,558
-3,130
-27% -$861K 0.06% 275
2020
Q2
$2.66M Buy
11,688
+8,956
+328% +$2.03M 0.05% 454
2020
Q1
$415K Sell
2,732
-764
-22% -$116K 0.02% 493
2019
Q4
$526K Sell
3,496
-17,530
-83% -$2.64M 0.01% 1113
2019
Q3
$2.98M Buy
21,026
+4,678
+29% +$663K 0.06% 197
2019
Q2
$2.05M Buy
16,348
+14,367
+725% +$1.8M 0.03% 320
2019
Q1
$218K Buy
+1,981
New +$218K 0.01% 1149
2018
Q4
Sell
-7,300
Closed -$901K 1430
2018
Q3
$901K Buy
7,300
+2,152
+42% +$266K 0.02% 566
2018
Q2
$511K Sell
5,148
-14,535
-74% -$1.44M 0.01% 747
2018
Q1
$1.74M Buy
19,683
+15,259
+345% +$1.35M 0.03% 345
2017
Q4
$437K Buy
4,424
+659
+18% +$65.1K 0.01% 821
2017
Q3
$362K Sell
3,765
-9,807
-72% -$943K 0.01% 1142
2017
Q2
$1.28M Buy
13,572
+219
+2% +$20.7K 0.02% 649
2017
Q1
$1.09M Buy
+13,353
New +$1.09M 0.01% 771
2016
Q4
Sell
-12,714
Closed -$947K 1659
2016
Q3
$947K Sell
12,714
-114,846
-90% -$8.55M 0.01% 651
2016
Q2
$9.68M Buy
+127,560
New +$9.68M 0.11% 52
2016
Q1
Sell
-5,388
Closed -$325K 1678
2015
Q4
$325K Sell
5,388
-7,387
-58% -$446K 0.01% 956
2015
Q3
$691K Buy
12,775
+7,475
+141% +$404K 0.02% 594
2015
Q2
$308K Sell
5,300
-1,860
-26% -$108K 0.01% 1107
2015
Q1
$431K Buy
+7,160
New +$431K 0.01% 744
2014
Q3
Sell
-23,238
Closed -$980K 1230
2014
Q2
$980K Buy
23,238
+112
+0.5% +$4.72K 0.04% 295
2014
Q1
$1.02M Sell
23,126
-76,914
-77% -$3.39M 0.07% 203
2013
Q4
$4.91M Buy
+100,040
New +$4.91M 0.25% 90
2013
Q3
Sell
-6,006
Closed -$211K 1196
2013
Q2
$211K Buy
+6,006
New +$211K 0.01% 816